Document is current
Any future updates will be listed below
-
Authors
Scholz, Phillip
Friede, Tim
Scholz, Karl Heinrich https://orcid.org/0000-0002-7624-5042
Grabmaier, Ulrich
Meyer, Thomas
Seidler, Tim
-
Funding
Funding for this research was provided by:
Herzzentrum Göttingen
- License Information
-
More Information
Article History
Received: 9 April 2024
Accepted: 17 July 2024
First Online: 1 August 2024
Declarations
:
: T. Friede declares personal fees for statistical consultancies (including data monitoring committees) from Actimed, Aslan, Bayer, BiosenseWebster, BMS, CSL Behring, Daiichi Sankyo, Enanta, Fresenius Kabi, Galapagos, IQVIA, Immunic, KyowaKirin, LivaNova, Minoryx, Novartis, PINK! gegen Brustkrebs, PPD, RECARDIO, Recordati, Relaxera, Roche, Servier, Viatris, Vifor, VICO Therapeutics; all outside the submitted work. U. Grabmaier reports an educational grant from Abbott, speaker fees from AstraZeneca, Abbott, Boehringer Ingelheim, and a research grant from German Center for Cardiovascular Research (DZHK e.V.). T. Seidler reports research or educational grants to the institution by Edwards Life Sciences and honoraria for lectures or advisory board consultations or travel grants from Abbott Vascular, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Corvia, Cytokinetics, Edwards Life Sciences, Medtronic, Myocardia, Novartis, Pfizer, and Teleflex. All other authors report no conflict of interests.
